[Autoantibodies as biomarkers].

Area of Science:

• Immunology
• Autoimmunity
• Biomarker Discovery

Context:

• Autoantibodies are direct consequences of autoimmune processes, arising from activated autoreactive B-lymphocytes.
• These autoantibodies are integral to the pathogenesis and clinical presentation of autoimmune diseases.
• Their presence can precede disease onset by years, highlighting their predictive potential.

Purpose:

• To elucidate the multifaceted role of autoantibodies in autoimmune diseases.
• To emphasize autoantibodies as diagnostic biomarkers and indicators of disease activity.
• To explore the predictive value of autoantibodies for disease occurrence, treatment response, and adverse effects.

Summary:

• Autoantibodies are key indicators in autoimmune diseases, reflecting disease activity and clinical manifestations.
• Their detection is vital for diagnosis and management, with titers correlating to disease progression.
• Autoantibodies can predict disease onset in healthy individuals and forecast responses to biologic therapies, including side effects.

Impact:

• Autoantibodies are indispensable tools for diagnosing and managing autoimmune conditions.
• Their utility spans from early prediction to therapeutic guidance and monitoring.
• Understanding autoantibody profiles enhances personalized medicine approaches in rheumatology and related fields.